Immunogen Inc
(IMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 12-1996 | 06-1996 | 12-1995 | 06-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,669 | 2,797 | 2,797 | 3,047 | 3,047 |
| Other current assets | 579 | 163 | 163 | 294 | 294 |
| TOTAL | $2,248 | $2,960 | $2,960 | $3,341 | $3,341 |
| Non-Current Assets | |||||
| PPE Net | 2,930 | 4,163 | 4,163 | 13,621 | 13,621 |
| Other Non-Current Assets | 0 | 1,383 | 1,383 | 84 | 84 |
| TOTAL | $2,930 | $5,546 | $5,546 | $13,705 | $13,705 |
| Total Assets | $6,350 | $8,506 | $8,506 | $17,046 | $17,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 733 | 733 | 2,229 | 2,229 |
| Accrued Expenses | 0 | 1,067 | 1,067 | 1,295 | 1,295 |
| TOTAL | $1,829 | $1,941 | $1,941 | $4,467 | $4,467 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,813 | 3,813 | 125 | 125 |
| TOTAL | $0 | $3,850 | $3,850 | $2,456 | $2,456 |
| Total Liabilities | $1,829 | $5,791 | $5,791 | $6,923 | $6,923 |
| Shareholders' Equity | |||||
| Common Shares | 218 | 166 | 166 | 126 | 126 |
| Retained earnings | 0 | -125,536 | -125,536 | -108,991 | -108,991 |
| Other shareholders' equity | 4,245 | 0 | 0 | 0 | 0 |
| TOTAL | $4,463 | $2,715 | $2,715 | $10,123 | $10,123 |
| Total Liabilities And Equity | $6,292 | $8,506 | $8,506 | $17,046 | $17,046 |